drugset / Trial / NCT05226533
Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Safety and efficacy of DWRX2003 combination with Remdesivir in moderate to severe COVID-19 patients will be confirmed.
Timeline
- Start
- 2022-03-31
- Primary completion
- 2022-12-16
- Completion
- 2022-12-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Niclosamide | Unknown | 432 mg | Other |
| Subject | Niclosamide | Unknown | 960 mg | Other |